Ganciclovir J Code: J1570

Drug & Product Overview

HCPCS Descriptor Injection, ganciclovir sodium, 500 mg

HCPCS Added Date January 1, 1994

Manufacturer Multiple Manufacturers

Route of Administration Intravenous

Generic Status Multi-Source; Generic

Dosage Type Single-Dose

Dosage Form Injection, Powder, Lyophilized, For Solution | Injection, Solution

About Ganciclovir

Ganciclovir is a medication aligned to the HCPCS J Code: J1570 for billing, pricing, and reimbursement purposes in the United States. It is an Antiviral drug administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: Ganciclovir is an anti-viral drug. It is used to prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ or bone marrow transplants. CMV disease can lead to serious infections in the body, including an infection in the eye, called CMV retinitis, that can cause blindness. Ganciclovir is also used to treat people with weakened immune systems (including people with AIDS) who have CMV retinitis. Ganciclovir works by slowing the growth of the CMV virus. It helps control CMV retinitis and decrease the risk of blindness. It also helps prevent the spread of infection to other areas of the body. Ganciclovir is not a cure for CMV disease. Some people may have worsening CMV retinitis even with treatment. It is important to have your eyes checked regularly by your doctor.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 9 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
00143-9299-10	Ganciclovir	Hikma Pharmaceuticals USA Inc.	10	500 MG / 10 ML
25021-0185-10	ganciclovir	Sagent Pharmaceuticals	25	500 MG / 10 ML
42023-0173-25	Ganciclovir	Endo USA, Inc.	25	500 MG / 10 ML
63323-0315-10	Ganciclovir	Fresenius Kabi USA, LLC	25	500 MG / 10 ML
70436-0089-55	ganciclovir	Slate Run Pharmaceuticals, LLC	25	500 MG / 10 ML
•••••-••••-•• Log in to view	Ganciclovir
	Ganciclovir
	Ganciclovir

Login to view 4 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Ganciclovir Pricing & Reimbursement

J1570 Private Payer Reimbursement

$35.27 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

Ganciclovir Sodium 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J1570	Generic Code (Multiple Manufacturers)	Ganciclovir Sodium	Injection, ganciclovir sodium, 500 mg
J1574	Exela Pharma Sciences	Ganciclovir Sodium	Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg

Ganciclovir CPT Administration Codes

CPT Code	Description
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Ganciclovir (J1570) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

Ganciclovir Medically Unlikely Edits (MUE)

The most billing units of J1570 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 500 mg.

Practitioner Office & Hospital Outpatient

4 units / day

= 2,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

Ganciclovir Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

CMV Disease Prevention in Transplant Recipients CMV Disease in Transplant Recipients CMV Retinitis Prevention of CMV Disease in Transplant Recipients

Drug Class

Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]DNA Polymerase Inhibitors [MoA]Nucleoside Analog Antiviral [EPC]Nucleoside Analog [EXT]

Frequently Asked Questions

Is there an available Ganciclovir billing and coding guide?

We have not yet identified a manufacturer source of Ganciclovir billing and coding information.

Are there any available Ganciclovir patient assistance programs?

Our team did not identify a source for Ganciclovir patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Ganciclovir prescribing information?

Ganciclovir prescribing information can be found at the link below: Visit Here →

Where can I find Ganciclovir side effect information?

Information regarding Ganciclovir's side effects can be found at MedlinePlus Visit Here →

Does billing Ganciclovir require JZ/JW wastage modifiers?

CMS has identified Ganciclovir(J1570) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.